CWD:NASDAQCaliberCos Inc. Analysis
Data as of 2026-03-28 - not real-time
$1.12
Latest Price
9/10Risk
Risk Level: High
Executive Summary
CaliberCos Inc. (CWD) is in a severe financial tailspin. Revenue has slumped 52.5% YoY to just $20 M, margins are deeply negative (gross margin ~7.5%, operating margin -30.8%, profit margin -108%), and the balance sheet is crippled by $93 M of debt versus only $2.9 M of cash, yielding a staggering debt‑to‑equity ratio of 355. The stock trades at $1.12, well below its 20‑day (1.304) and 50‑day (1.279) SMAs, with a bearish MACD and an RSI of 38, indicating limited upside momentum. Volatility is extreme at 72% over the past 30 days, and beta (1.09) suggests the share moves more than the market.
Technical pressure is compounded by liquidity concerns highlighted in the recent earnings call, where management cited delayed revenue and a need for cost‑saving measures while attempting to diversify into digital assets. The price is hovering near the identified support of $1.06 and faces resistance around $1.55, with volume trending upward, yet the underlying fundamentals and high leverage make any upside highly speculative.
Technical pressure is compounded by liquidity concerns highlighted in the recent earnings call, where management cited delayed revenue and a need for cost‑saving measures while attempting to diversify into digital assets. The price is hovering near the identified support of $1.06 and faces resistance around $1.55, with volume trending upward, yet the underlying fundamentals and high leverage make any upside highly speculative.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish technical indicators (price below SMAs, MACD bearish)
- Severe liquidity strain and high debt load
- Elevated volatility and low market cap
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside from digital‑asset diversification
- Cost‑saving initiatives may improve cash flow
- Continued balance‑sheet weakness limits confidence
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Uncertain turnaround prospects amid structural losses
- High leverage could force restructuring or dilution
- Sector exposure to real‑estate cycles and emerging digital assets
Key Metrics & Analysis
Financial Health
Revenue Growth-52.50%
Profit Margin-108.46%
P/E Ratio-4.3
ROE-122.86%
ROA-3.93%
Debt/Equity354.94
P/B Ratio5.8
Op. Cash Flow$-12065000
Free Cash Flow$-17311750
Industry P/E16.0
Technical Analysis
TrendNeutral
RSI38.4
Support$1.06
Resistance$1.55
MA 20$1.30
MA 50$1.28
MA 200$2.66
MACDBearish
VolumeIncreasing
Fear & Greed Index65.98
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta1.09
Volatility72.61%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.